Spark Therapeutics, Inc. Overview
Company Headquarters: Pennsylvania, Pennsylvania, US
Founded: 2013
Workforce: 320+
Company Working:
Spark Therapeutics, Inc. is a research-based company which is involved in development and marketing of products related to the gene therapy. The company focuses on developing effective treatments for disorders such as inherited retinal diseases (IRDs), neurodegenerative diseases, lysosomal storage disorders, blindness, hemophilia, and other genetic diseases. Their products are unique and used for the treatment of rare disorders. Moreover, the company is developing innovative products with the help of research and development department, its preclinical trials are focused on developing treatment for inherited retinal diseases. Spark Therapeutics, Inc. has state-of-the-art cGMP manufacturing facility which is approved by Food and Drug Administration (FDA).
Strategy
Spark Therapeutics, Inc. focuses on collaboration activities and partnerships with major players and licensing agreements. The company is conducting various clinical programs and it emphasizes on developing medical solutions for the treatment of rare inherited diseases. Moreover, the company aims to provide viral vectors to the major pharmaceutical players in the market for manufacturing of products related to the gene therapy. The company is entering into long term agreements with business partners in order to strengthen its position in the market.
Tech - adeno-associated viral (AAV) vector platform
